[HTML][HTML] The therapeutic potential of apelin in kidney disease

FA Chapman, D Nyimanu, JJ Maguire… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) is a leading cause of global morbidity and mortality and is
independently associated with cardiovascular disease. The mainstay of treatment for CKD is …

[HTML][HTML] Fish feed intake, feeding behavior, and the physiological response of apelin to fasting and refeeding

D Assan, Y Huang, UF Mustapha, MN Addah… - Frontiers in …, 2021 - frontiersin.org
Feed is one of the most important external signals in fish that stimulates its feeding behavior
and growth. The intake of feed is the main factor determining efficiency and cost, maximizing …

Mechanism of endothelial dysfunction in chronic kidney disease

J Malyszko - Clinica chimica acta, 2010 - Elsevier
Endothelium is the largest organ in the body strategically located between the wall of blood
vessels and the blood stream. The human body contains approximately 1013 endothelial …

Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure

AG Japp, NL Cruden, G Barnes, N Van Gemeren… - Circulation, 2010 - Am Heart Assoc
Background—Apelin, the endogenous ligand for the novel G protein–coupled receptor APJ,
has major cardiovascular effects in preclinical models. The study objectives were to …

Vascular effects of apelin in vivo in man

AG Japp, NL Cruden, DAB Amer, VKY Li… - Journal of the American …, 2008 - jacc.org
Objectives: This study was designed to establish the direct vascular effects of apelin in vivo
in man. Background: Apelin is the endogenous ligand for the previously orphaned G-protein …

Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction

KF Docherty, RT Campbell, KJM Brooksbank… - Circulation, 2021 - Am Heart Assoc
Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction
are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin …

International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function

SL Pitkin, JJ Maguire, TI Bonner, AP Davenport - Pharmacological reviews, 2010 - ASPET
A gene encoding a novel class a G-protein-coupled receptor was discovered in 1993 by
homology cloning and was called APJ. It was designated an “orphan” receptor until 1998 …

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis

M Eyries, G Siegfried, M Ciumas, K Montagne… - Circulation …, 2008 - Am Heart Assoc
Apelin has been identified as the endogenous ligand of the human orphan G protein–
coupled receptor APJ. This peptide exerts a variety of cardiovascular effects and particularly …

Apelin, a promising target for type 2 diabetes treatment?

I Castan-Laurell, C Dray, C Knauf, O Kunduzova… - Trends in Endocrinology …, 2012 - cell.com
Insulin resistance is a main feature of obesity and type 2 diabetes mellitus (T2DM). Several
mechanisms linking obesity to insulin resistance have been proposed. Adipose tissue …

[HTML][HTML] Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system

P Yang, JJ Maguire, AP Davenport - Trends in pharmacological sciences, 2015 - cell.com
Apelin and its G protein-coupled receptor (GPCR) have emerged as a key signalling
pathway in the cardiovascular system. The peptide is a potent inotropic agent and …